2 - 4 December 2021 Sydney Australia

International Faculty Members Include

Iris Baumgartner
Iris Baumgartner

Head of Angiology and Director of Vascular Research University Hospital Bern Switzerland

Iris is Professor for Internal Medicine with a focus on Vascular Medicine. Her particular research interst is in endovascular therapy, congenital vascular malformation and precision medicine with translation to vascular medicine.

She graduated in human medicine at the University of Hannover, Germany, in 1986 and was trained in Internal Medicine and Vascular Medicine at the University Hospital Zurich (Switzerland), Düsseldorf (Germany) and Bern (Switzerland). Since 2006, she has been the Director of the Division Angiology, Swiss Cardiovascular Center, at the Inselspital, University Hospital Bern and since 2012 Vice-Dean of the Medical Faculty of the University Bern.

She dedicates herself to the diagnosis and interventional treatment of congenital vascular malformations as part of the spectrum of rare vascular diseases.. The “Interdisciplinary Center for Vascular Interven-tions”, at the Inselspital, University Hospital Bern, was established on her initiative in 2009. Development of Vascular Research at the University Hospital Bern is coordinated by an independent “Clinical Investiga-tion Unit, Vascular Medicine” and supported by an “International Advisory Board”.

Iris is a member of various Editorial Boards (JACC, EHJ), has published widely.

Sven Braunlich
Sven Braunlich

Senior Consultant, Division of Interventional Angiology, University Hospital, Leipzig, Germany

Sven has been working with Dierk Scheinert since 2002. His focus is on state-of-the-art interventional therapy of all kinds of PAOD, especially lower extremeties, CTO’s, CLI and BTK in a high volume centre with more than 4000 interventions per year. His other interest is on all modalities of aortic repair, carotid artery stenting, renal artery stenting and denervation, as well as novel treatment options like drug eluting technology and atherectomy.

He has been a co-organiser of LINC, which now sees 5000 attending from more than 80 countries, and is a member of the faculty and co-organiser of LAP – LINC Asia-Pacific in Hong Kong. He is a live case operator and faculty at leading medical conferences, including LINC, LINC Asia-Pacific, VERVE, VIVA, TCT, NCVH, Cirse, and Charing Cross.

Marianne Brodmann
Marianne Brodmann

Vascular Specialist, Division of Angiology, Medical University,
Graz Austria

Since 2013 Marianne has been a member of the nucleus of the European Society of Vascular Medicine, is a longstanding member of the UEMS Board of Angiology and was President of the ÖGIA (Austrian Society of Angiology) from 2012 to 2014. Her research interests include anticoagulation and thrombolysis; new endovascular technologies in the peripheral field; and evaluation of nature of restenosis and has participated in 50 international clinical trials. She was President of the Working Group Peripheral Circulation of the European Society of Cardiology from 2014 to 2016.

Venita Chandra
Venita Chandra

Clinical Associate Professor of Surgery Division of Vascular Surgery Stanford USA.

Venita is also the Medical Director of the Stanford Advanced Wound Center, the Associate Program Director of the Vascular Surgery Fellowship and the Vascular Surgery Medical Student Clerkship Director.

She is the founder of the Stanford Extremity Preservation Program (StEPP), has substantial expertise in new and cutting edge peripheral vascular and limb salvage techniques, and works to optimize the management of patients and education of residents and fellows in this complex field.

Her research and clinical interests include limb salvage, technology development and treatment optimization for complex open and endovascular approaches to peripheral vascular and aneurysmal disease.

Koen Deloose
Koen Deloose

Head of Vascular Surgery Department AZ Sint-Blasium Dendermonde Belgium

Koen is a vascular surgeon and currently Medical Director of the Diabetic Wound Clinic and Assistant Director of the Department of Surgery and Vascular Surgery at AZ Sint-Blasium Dendermonde Belgium.

As an active researcher, Dr Deloose has authored and co-authored more than 60 peer reviewed medical journals, contributed to more than 10 chapters in orthopaedic, vascular, and endovascular books as well as many posters and papers in conference proceedings. He is a member of the International Editorial Board, Endovascular Section of the Journal of Cardiovascular Surgery and Editorial Advisory Board Member of Endovascular Today. He is also a teacher and proctor for several medical device companies in-hospital and in his co-owned animal lab in Belgium. He is a member of many committees and boards including the Royal Belgian Society of Surgery and Treasurer of the Belgian Society of Vascular Surgery. He is founding President of the Belgium Young Flownmasters, a Belgian working for young and ambitious vascular surgeons.

Michael Jaff
Michael Jaff

Vice-President of Clinical Affairs, Technology and Innovation at Boston Scientific Corporation USA

Michael is a professor of medicine at Harvard Medical School and was the President of Newton-Wellesley Hospital from October 2016-December 2019. Prior to that, he was the inaugural Paul and Phyllis Fireman Endowed Chair of Vascular Medicine and Medical Director of the Fireman Vascular Center at the Massachusetts General Hospital.

He is an expert in all aspects of vascular medicine, including peripheral artery disease, venous thromboembolic disease, aneurysmal diseases, and all diagnostic strategies in vascular medicine. Michael founded VasCore, the Vascular Ultrasound Core Laboratory, the largest of its’ kind in the United States. The laboratory has participated in trial design and independent analysis of vascular laboratory images for over 200 prospective multicenter peripheral vascular device and pharmaceutical trials across 66 countries.

Michael has published extensively, in the field of Vascular Medicine with over 300 peer-reviewed publications and 10 textbooks, is the Past-President of the Society for Vascular Medicine and Biology and was the first physician to have received the designation as Master of the Society for Vascular Medicine.

Osamu Iida
Osamu Iida

Associate Director of the Cardiovascular Centre, Kansai Rosai Hospital, Japan

Osamu is an established and highly skilled physician with over seventeen years of experience. He has a great deal of experience in the endovascular treatment, specifically vessels of thoracic, abdominal and lower limbs with more than 1,000 cases per year. He also serves as the Chief of Coronary, Endovascular, and Structure Treatments. He was selected Best Doctors in Japan 2016-2017 by Teradoc, Inc.

As a researcher, he has published 35 original papers as a first author and co-authored more than 150 papers. His main research interests are clinical research of SFA treatment using IVUS, research about angiosome (CLI single-site study), various studies which impact many treatment strategies (CLI multicenter study).

Raghu Kolluri
Raghu Kolluri

Medical Director of Syntropic Core Lab at Ohio Health Research and Innovation Institute USA

Raghu directs the Vascular Medicine Service Line and Vascular Laboratories across 12 hospitals in central Ohio. As the Director of Vascular Medicine, at Prairie Cardiovascular, he established and regionalized vascular laboratories and also established a Wound Core Lab.

Known as a vascular educator, Raghu has been invited to organize and lecture at several cardiovascular conferences across the world. He co-founded The VEINS meeting in 2011, founded the SVM Fellows and SVM Advanced Practice Provider review courses. He is currently President of the Society for Vascular Medicine, serves as a reviewer for several cardiovascular journals and is on the editorial board for Vascular Medicine Journal and Annals of Vascular Surgery. His clinical and research interests include non-invasive testing, deep venous thrombosis, critical limb ischemia, and chronic venous disease.

Miguel Montero-Baker
Miguel Montero-Baker

Vascular and Endovascular Surgeon Baylor College of Medicine Houston Texas USA

Miguel specialises in diabetic foot amputation prevention and limb salvage.

Miguel is an Associate Professor in the Division of Vascular Surgery and Endovascular Therapy in the Baylor College of Medicine Houston Texas USA, specialising in Diabetic Foot Amputation Prevention and Limb Salvage.

He is author of numerous journal publications, has co-authored several textbook chapters and is a well-recognized opinion leader for the Latin American medical community. His main clinical interests are critical limb ischemia, implantable micro-technology and endovascular carotid disease management.

Miguel is an active member of the Society for Vascular Surgery, the International Society for Vascular Surgery, the International Society of Endovascular Surgeons, Endovascular Surgeons of Latin America and the Latin America Society of Vascular Surgeons.

Erin Murphy
Erin Murphy

Director of the Venous and Lymphatic Institute Sanger Heart and Vascular Atrium Health Carolina USA

Erin specialises in venous and lymphatic disease and performs the breadth of vascular surgery related to this specialisation and is dedicated to the advancement of the field.
She has extensive research experience in the field of vascular surgery and has authored over 50 medical journal articles, book chapters and editorials.

Erin has presented at numerous national and international meetings and has received a number of awards for her contributions. She serves on the editorial board for the Journal of Endovascular Therapy (JEVT), is actively involved in ongoing clinical trials and is currently serving as the US national primary investigator for the Medtronic Abre Stent.

Tatsuya Nakama
Tatsuya Nakama

Chief Physician, Department of Cardiology, Tokyo Bay Uravasu Ishikawa Medical Centre, Japan

Tatsuya moved from Chief of Cathererization Laboratory, Department of Cardiology at the Miyazaki Medical Association Hospital in 2018 to his new position as Chief Physician in the Department of Cardiology at the Tokyo Bay Uravasu Ichikawa Medical Centre.

He has published widely, participated in numerous conferences and is a member of many LINC faculties.

Robert Rhee
Robert Rhee

Clinical Professor of Surgery, State University of New York, Downstate; Chief of Vascular Surgery, Maimonides Medical Center, New York USA

Robert is an international leader in the treatment of complex aortic diseases. He has extensive experience in both direct surgical and endovascular management of abdominal, thoracic and thoracoabdominal aortic aneurysms and dissections. He has been involved with, and has led, significant vascular device clinical trials since 1995.

He continues to bring the latest technologies to residents of NYC by offering minimally-invasive treatment options as well as state of the art therapies in clinical trials, including fenestrated and branched graft aortic endovascular repair.

Robert is the Co-Director of the Brooklyn Aortic Center serving over 2 million people in the region, has published well over 100 articles in leading journals and textbooks, has lectured in 22 different countries and is currently the President-Elect of the Eastern Vascular Society.

Mehdi Shishehbor
Mehdi Shishehbor

Director Endovascular Services University Hospitals Cleveland Medical Center, USA

Mehdi is the Co-Chair of the Clinical Executive Committee, Director of the Cardiovascular Interventional Center, Co-Director of the Vascular Center, and the Medical Director of UH CMC Cardiac Catheterization Laboratory. His area of expertise includes vascular medicine and minimally invasive, catheter-based procedures such as angioplasty, stent grafts, stenting, atherectomy and intravascular ultrasound to treat coronary, carotid, abdominal aortic aneurysms, and peripheral arterial and venous diseases.
He is an expert on minimally invasive approaches to reconstruct lower extremity arteries in order to treat critical limb ischemia and prevent amputation. His work in this area has been recognized locally, nationally and internationally.

Prior to joining University Hospitals, he directed the Endovascular Program at the Cleveland Clinic from 2009 to May 2017 and trained over 40 interventional fellows and over 400 physicians nationally on advanced techniques for limb salvage.

Jean-Paul De Vries
Jean-Paul De Vries

Head Department of Surgery University Medical Centre Groningen the Netherlands

Paul’s extensive experience is in open and endovascular treatment of complex thoracic and abdominal aortic aneurysms. The UMCG Department of Vascular Surgery is a tertiary referral centre for vascular –aortic- graft infections as well as carotid disease and complex peripheral arterial disease.

He has published widely, is the PI of the global ANCHOR registry regarding the use of EndoAnchors in EVAR. His main topics of research are tissue perfusion measurements in patients with PAOD, improved imaging techniques for determination of endograft apposition post-TEVAR and post-EVAR and the implementation of telemonitoring in vascular patients.

VERVE Symposium Update

Due to Covid-19, the 2020 Verve Symposium has been postponed to 2021. More information is available here.

We will keep you updated via our website or contact the Symposium Secretariat.